CBD Nutraceuticals Market - By Product Type, Application, Distribution Channel, Forecast, 2025 - 2036

CBD Nutraceuticals Market Size

The global CBD nutraceuticals market size was valued at USD 12.45 billion in 2025 and is projected to grow at a robust CAGR of more than 17.6% from 2026 to 2034, reaching nearly USD 53.1 billion by 2034, according to the latest report by Global Market Insights Inc.

This growth is primarily driven by increasing awareness of cannabidiol’s benefits in managing chronic health conditions and supporting overall wellness. According to the report by Brightfield Group, sales of CBD products in the US were around USD 5.3 billion in 2021 and are expected to grow to nearly USD 16 billion by 2026. This strong growth shows the rising demand and popularity of CBD nutraceuticals for in the market.
 

Consumer spending on clean label, plant-based, health-enhancing, and innovative products aimed at chronic condition management greatly drives this market. AI personalization tools have also significantly impacted customer interaction and product recommendations. This, along with the shift toward sustainable organic CBD farming, shows changes in consumer preferences. These sustainable and low-cost extraction farming methods are beneficial for both new and existing market manufacturers, leading to wider industry growth. Also, wellness brands, researchers, and regulatory bodies are actively developing standardized and safer CBD products, driving the market growth.
 

The market of CBD nutraceuticals includes dietary supplements and fortified functional foods and beverages with CBD derived from hemp or cannabis plants. These products focus on health and wellness applications, including stress management, pain relief, and sleep improvement.
 

CBD Nutraceuticals Market Trends

The market is witnessing rapid expansion, driven by rising consumer demand for natural health supplements, increasing research on CBD’s health benefits, and evolving regulatory frameworks. Key trends in the CBD nutraceuticals industry indicate growing acceptance of CBD-based wellness products as part of preventive and supportive healthcare solutions.
 

The rising prevalence of chronic diseases, including arthritis, diabetes, and cardiovascular disorders, continues to drive market growth. According to the CDC, approximately 38.4 million Americans, representing nearly 11.6% of the total population, are affected by diabetes, highlighting the increasing need for accessible and affordable CBD nutraceutical products for disease management and improved quality of life.
 

The use of CBD supplements for chronic pain management is expanding due to their anti-inflammatory and analgesic properties. In addition, CBD is increasingly used to support mental health by helping reduce anxiety and depression. As per WHO estimates, more than 1 billion people worldwide suffer from mental health disorders, emphasizing the importance of innovative, inclusive, and patient-centric CBD wellness solutions that promote equitable access to mental healthcare.
 

The growing trend toward herbal and plant-based medicine is further strengthening CBD acceptance and driving emerging trends in CBD nutraceuticals. Manufacturers are focusing on product innovation through the development of capsules, tinctures, gummies, and infused beverages, supporting the future growth of the CBD supplements market while catering to diverse consumer preferences.
 

CBD Nutraceuticals Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on the product type, the market is segmented into CBD oils, CBD tinctures, CBD capsules and softgels, CBD gummies and chews, and other product types. The CBD oils segment dominated the market with USD 4.11 billion in 2025
 

• Cannabidiol oil are popular for their efficiency and ease of use in the current market. These oils are beneficial because they are administered through the sublingual route, which greatly improves their absorption and provides beneficial effects. These oils are formulated in low to high ranges of CBD concentration to meet consumer needs in reducing stress through chronic pain management.
   
• This segment is expected to grow further because of new knowledge about cannabidiol as a natural alternative to medicines. Product innovation, such as flavored oils and combination products with vitamins or essential oils, has increased their appeal. Additionally, improved regulations and growing global interest in wellness products drive the market share of these oils further, especially with CBD.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the CBD nutraceuticals market is segmented into pain management, anxiety and stress reduction, sleep disorders, mental health, and other applications. Among these, the pain management segment held a significant market share of 35.5% in 2025, reflecting the strong demand for CBD-based pain relief solutions.
 

• Pain management remains the leading segment, supported by the growing prevalence of chronic pain conditions such as arthritis, neuropathy, and fibromyalgia. The increasing burden of these disorders has strengthened the need for effective, accessible, and safer alternatives to conventional treatment options within the CBD nutraceuticals market.
   
• CBD’s anti-inflammatory and analgesic properties have enhanced its acceptance as a substitute for traditional pain medications, which are often associated with adverse side effects and dependency risks. Its non-addictive nature has further encouraged adoption among healthcare professionals and patients seeking long-term pain management solutions.
   
• In addition, CBD has demonstrated potential in reducing inflammation and nerve-related pain, contributing to rising demand for pain-focused nutraceutical products. The growing incidence of pain-related disorders, combined with continuous innovation in specialized capsule, topical cream, and targeted formulation development, is driving sustained growth in the pain management segment and strengthening the overall market analysis.
   

Looking for region specific data?

Download Free PDF

Based on distribution channel, the CBD nutraceuticals market is divided into retail stores, pharmacies, e-commerce, and other distribution channels. The retail stores segment dominated the market in 2025 and is expected to reach USD 20.1 billion within the forecast period.  
 

• Retail stores serve as the most widespread distribution channel for CBD nutraceutical products, which gives consumers immediate access to a wide selection of CBD products.
   
• Retail stores help consumers by providing them guidance on product knowledge and also suggest appropriate products for their needs.
   
• Physical stores are convenient for customers who want to confirm the legitimacy of a product.
   
• In addition, special marketing activities such as advertising and consumer sampling in retail outlets encourage customers to visit these outlets, thereby strengthening retail stores as the dominant channel of distribution for CBD nutraceuticals.
   

North America CBD Nutraceuticals Market

The United States leads the North American market and is expected to grow at a CAGR of 17.5%, reaching approximately USD 25.7 billion by the end of 2034. This strong growth reflects the country’s dominant position in the global CBD nutraceuticals industry and its expanding role in the development of cannabis-derived health products.

 

• The U.S. CBD nutraceuticals industry is the largest globally due to favorable regulations, high consumer awareness, and increasing acceptance of cannabis-derived products. The growing prevalence of chronic diseases including arthritis and anxiety disorders among the U.S. population has boosted the demand for CBD-based health solutions including nutraceuticals.
   
• The expansion of the market is supported by major players as well as extensive retail network. In addition, CBD products benefit from changing wellness and holistic healthcare trends. The market grows further due to the increasing availability of CBD food and drinks in retail stores and online shops.
   
• On the other hand, leading consumer states such as California and Colorado with advanced cannabis laws also strengthen the market through research innovations.
   

Europe CBD Nutraceuticals Market

The Germany market is experiencing robust growth in Europe market.  
 

• Germany leads Europe’s CBD nutraceutical market due to its progressive regulations towards cannabis as well as the current use of nature-oriented health remedies.
   
• Germany's advanced healthcare infrastructure and focus on treatment options have increased interest in CBD products for managing chronic pain, stress, and insomnia.
   
• German pharmacies and wellness stores offer CBD products, thus improving overall access. Germany’s stringent quality requirements also greatly help German consumers. The market is strengthened by partnerships between local suppliers and foreign CBD companies.
   

Asia Pacific CBD Nutraceuticals Market

The Asia Pacific market is growing at 17.8% during the analysis period, with China dominating the regional market share.
 

• China's traditional medicine market is growing, and people are more interested in wellness products. This is helping CBD nutraceutical products become more popular. While cannabis has many restrictions, CBD is legal in cosmetics and is now being used in nutraceutical products for health benefits.
   
• Chinese consumers are moving toward CBD supplements and oils as they want more plant-based ingredients. Local companies are making more CBD products in China to meet this growing demand.
   
• Online shopping websites and social media campaigns are helping more people learn about CBD products. The market's future growth depends on new regulations and how well people understand the health benefits of CBD.
   

Latin America CBD Nutraceuticals Market

The Brazil market is experiencing robust growth in Latin America market.
 

• Brazil's CBD nutraceutical market is expanding, driven by recent regulatory reforms and growing consumer interest in alternative health products. The approval of medical cannabis products by Brazil's health regulatory agency (ANVISA) has helped support the use of CBD in wellness applications.
   
• The high prevalence of chronic diseases such as epilepsy, anxiety, and neuropathic pain conditions has increased the demand for CBD supplements and oils. The access to medicines, specialty stores, pharmacies, and e-commerce stores makes CBD and its derivatives more accessible to the consumer market.
   

Middle East and Africa CBD Nutraceuticals Market

The Saudi Arabia CBD nutraceuticals industry is witnessing substantial growth in Middle East and Africa.
 

• The CBD nutraceutical market is still in its initial stage in Saudi Arabia, but there is a positive expectation of growth owing to changing social norms and greater publicity of CBD health products. There are still strict laws on cannabis and drugs, but there is increasing acceptance for hemp-derived CBD without THC.
   
• Saudi consumers are increasingly preferring herbal medicine, natural and plant-based health products. The entry of new foreign brands into the market through deals with local distributors as well as online retailing is essential for market development.
   

CBD Nutraceuticals Market Share

The top 5 companies in the market account for ~65% of the market share, including Bluebird Botanicals, Charlotte's Web, CV Sciences, Diamond CBD, and Elixinol. These companies maintain dominance through product innovation, organic certifications, and strategic partnerships that meet the growing demand for wellness-focused CBD solutions.
 

Additionally, companies are expanding their portfolios with water-soluble CBD, nano-emulsification, and broad-spectrum formulations to enhance bioavailability and effectiveness. For example, Charlotte’s Web and Green Roads are known for creating full-spectrum CBD oils and gummies for consumers seeking holistic health benefits.
 

To stay competitive, firms are investing in research and development for new delivery systems, such as CBD capsules, soft gels, and topicals. They are also expanding into products for sleep, stress, and recovery. These improvements are helping the market grow and bringing new innovations.
 

CBD Nutraceuticals Market Companies

Major players operating in the CBD nutraceuticals industry are:

• Bluebird Botanicals
• Charlotte's Web
• CV Sciences
• Diamond CBD
• Elixinol
• ENDOCA
• Foria Wellness
• Garden of Life (Nestle)
• Green Roads
• Irwin Naturals
• Isodiol
• Medical Marijuana
• MEDTERRA
   
• Charlotte's Web offers premium full-spectrum CBD oils formulated for overall wellness. Their flagship Original Formula CBD Oil helps promote relaxation and supports recovery from stress or exercise-induced inflammation.
   
• Green Roads specializes in pharmacist-formulated CBD products, including their CBD Relax Bears, which are designed to provide stress relief with precisely measured dosages for consistent results.
   
• MEDTERRA focuses on THC-free CBD solutions, such as their CBD Sleep Capsules, which combine CBD with melatonin to support restful sleep and improve overall nighttime recovery.
   

CBD Nutraceuticals Industry News

• In February 2024, Green Roads launched its new CBD Puffs, expanding its product lineup in the CBD Nutraceuticals Industry with a convenient, flavorful format designed to support wellness and relaxation for consumers seeking alternative health solutions.
   
• In March 2023, CV Sciences launched a new line of THC-free gummies and softgels. This expansion strengthens their position in the market, offering consumers alternative, non-psychoactive options for wellness and health benefits.
  
   

The CBD nutraceuticals market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• CBD oils
• CBD tinctures
• CBD capsules and softgels
• CBD gummies and chews
• Other product types

Market, By Application

• Pain management
• Anxiety and stress reduction
• Sleep disorders
• Mental health
• Other applications

Market, By Distribution Channel

• Retail stores
• Pharmacies
• E-commerce
• Other distribution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• MEA
  • South Africa
  • Saudi Arabia
  • UAE